A1EPH
2-[2-(1,3-oxazol-2-yl)-5-[4-(4-propan-2-yloxyphenyl)sulfonylpiperazin-1-yl]phenoxy]ethanoic acid
| Created: | 2025-04-18 |
| Last modified: | 2026-10-28 |
Find Related PDB Entry |
|---|
Find related ligands:Help |
|---|
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 62 |
| Chiral Atom Count | 0 |
| Bond Count | 65 |
| Aromatic Bond Count | 17 |
Chemical Component Summary | |
|---|---|
| Name | 2-[2-(1,3-oxazol-2-yl)-5-[4-(4-propan-2-yloxyphenyl)sulfonylpiperazin-1-yl]phenoxy]ethanoic acid |
| Synonyms | Asapiprant |
| Systematic Name (OpenEye OEToolkits) | 2-[2-(1,3-oxazol-2-yl)-5-[4-(4-propan-2-yloxyphenyl)sulfonylpiperazin-1-yl]phenoxy]ethanoic acid |
| Formula | C24 H27 N3 O7 S |
| Molecular Weight | 501.552 |
| Type | NON-POLYMER |
Chemical Descriptors | |||
|---|---|---|---|
| Type | Program | Version | Descriptor |
| SMILES | CACTVS | 3.385 | CC(C)Oc1ccc(cc1)[S](=O)(=O)N2CCN(CC2)c3ccc(c(OCC(O)=O)c3)c4occn4 |
| SMILES | OpenEye OEToolkits | 2.0.7 | CC(C)Oc1ccc(cc1)S(=O)(=O)N2CCN(CC2)c3ccc(c(c3)OCC(=O)O)c4ncco4 |
| Canonical SMILES | CACTVS | 3.385 | CC(C)Oc1ccc(cc1)[S](=O)(=O)N2CCN(CC2)c3ccc(c(OCC(O)=O)c3)c4occn4 |
| Canonical SMILES | OpenEye OEToolkits | 2.0.7 | CC(C)Oc1ccc(cc1)S(=O)(=O)N2CCN(CC2)c3ccc(c(c3)OCC(=O)O)c4ncco4 |
| InChI | InChI | 1.06 | InChI=1S/C24H27N3O7S/c1-17(2)34-19-4-6-20(7-5-19)35(30,31)27-12-10-26(11-13-27)18-3-8-21(24-25-9-14-32-24)22(15-18)33-16-23(28)29/h3-9,14-15,17H,10-13,16H2,1-2H3,(H,28,29) |
| InChIKey | InChI | 1.06 | ZMZNWNTZRWXTJU-UHFFFAOYSA-N |
Drug Info: DrugBank
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| DrugBank ID | DB20492 |
|---|---|
| Name | Asapiprant |
| Groups | investigational |
| Description | Asapiprant is a small molecule drug. Asapiprant is under investigation in clinical trial NCT04705597 (Study to Evaluate the Safety, Tolerability, and Efficacy of BGE-175 in Hospitalized Adults With Coronavirus Disease 2019 (COVID-19) That Are Not in Respiratory Failure). Asapiprant has a monoisotopic molecular weight of 501.16 Da. |
| Synonyms |
|
| Categories |
|
| CAS number | 932372-01-5 |
Drug Targets
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| Name | Target Sequence | Pharmacological Action | Actions |
|---|---|---|---|
| Prostaglandin D2 receptor | MKSPFYRCQNTTSVEKGNSAVMGGVLFSTGLLGNLLALGLLARSGLGWCS... | unknown | antagonist |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
| Resource Name | Reference |
|---|---|
| PubChem | 59232326 |
| ChEMBL | CHEMBL3545043 |